Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CURE H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 61 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pujade-Lauraine, E; Cure, H; Battista, C; Guastalla, JP; Chiurazzi, B; Fabbro, M; Tubiana-Mathieu, N; Bourgeois, H; Lioure, B; Paraiso, D; Lotz, JP
      High dose chemotherapy in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    2. Ledermann, JA; Herd, R; Maraninchi, D; Viens, P; Buclon, M; Philip, T; Cure, H; Lotz, JP; Chauvin, F; Ferrante, P; Rosti, G
      High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

      ANNALS OF ONCOLOGY
    3. Bernard-Gallon, DJ; De Latour, MP; Hizel, C; Vissac, C; Cure, H; Pezet, D; Dechelotte, PJ; Chipponi, J; Chassagne, J; Bignon, YJ
      Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas

      ANTICANCER RESEARCH
    4. Le Bouedec, G; Auvray, H; Cure, H; de Latour, M; Penault-Llorca, F; Dauplat, J
      Uterine sarcoma in patients receiving tamoxifen therapy: two cases.

      REVUE DE MEDECINE INTERNE
    5. Le Bouedec, GL; Cure, H; de Latour, M; Dauplat, J
      Stewart-Treves syndrome postmastectomy for breast cancer. One case.

      REVUE DE MEDECINE INTERNE
    6. Cure, H; Bay, JO; Plagne, R; Chollet, P; Dauplat, J
      High-dose chemotherapy in advanced epithelial ovarian cancer

      BULLETIN DU CANCER
    7. Cutuli, B; Janvier, M; de la Rochefordiere, A; Julien, JP; Isambert, N; Alzieu, C; Kerbrat, P; de Lafontan, B; van Lemmens, L; Cure, H; Ganem, G; Baume, D; Le Mevel, A; Lorthoraly, A; de Gislain, C; Marchal, C; Chevelle, C; Lauche, H; Serin, D
      Leukemias and preleukemic states developing after treatment of breast cancer

      PRESSE MEDICALE
    8. Charrier, S; Chollet, P; Bay, JO; Cure, H; Kwiatkowski, F; Portefaix, G; Communal, Y; Betail, G; Plagne, R; Chassagne, J
      Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer

      BONE MARROW TRANSPLANTATION
    9. Cure, H; Chevalier, V; Pezet, D; Bousquet, J; Focan, C; Levi, F; Garufi, C; Chipponi, J; Chollet, P
      Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer

      ANTICANCER RESEARCH
    10. Roche, H; Cure, H; Adenis, A; Fargeot, P; Terret, C; Lentz, MA; Madelmont, JC; Fumoleau, P; Hanauske, A; Chollet, P
      Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults

      JOURNAL OF NEURO-ONCOLOGY
    11. Cure, H; Dauplat, J; Chollet, P
      First line chemotherapy for advanced ovarian cancer in 2000: standards andquestions

      BULLETIN DU CANCER
    12. Michallet, M; Tanguy, ML; Socie, G; Thiebaut, A; Belhabri, A; Milpied, N; Reiffers, J; Kuentz, M; Cahn, JY; Blaise, D; Demeocq, F; Jouet, JP; Michallet, AS; Ifrah, N; Vilmer, E; Molina, L; Michel, G; Lioure, B; Cavazzana-Calvo, M; Pico, JL; Sadoun, A; Guyotat, D; Attal, M; Cure, H; Bordigoni, P; Sutton, L; Buzyn-Veil, A; Tilly, M; Leporrier, M; Fegueux, N; Dreyfus, F; Rio, B; Lutz, P; Vernant, JP
      Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

      BRITISH JOURNAL OF HAEMATOLOGY
    13. Lotz, JP; Cure, H; Janvier, M; Morvan, F; Legros, M; Asselain, B; Guillemot, M; Roche, H; Gisselbrecht, C
      High-dose chemotherapy with autologous hematopoietic stem cell support formetastatic breast cancer: Results of the French Pegase 04 protocol

      HEMATOLOGY AND CELL THERAPY
    14. Cure, H; Souteyrand, P; Ouabdesselam, R; Roche, H; Ravaud, A; D'incan, M; Viens, P; Fargeot, P; Lentz, MA; Fumoleau, P; Hanauske, A; Chollet, P
      Results of a phase II trial with cystemustine at 90 mg/m(2) as a first- orsecond-line treatment in advanced malignant melanoma: a trial of the EORTCClinical Studies Group

      MELANOMA RESEARCH
    15. Le Bouedec, G; Charrier, S; Cure, H; de Latour, MP; Ferriere, JP; Chollet, P; Dauplat, J
      Role for surgery after complete clinical response to neoadjuvant chemotherapy for breast cancer

      PRESSE MEDICALE
    16. Viens, P; Palangie, T; Janvier, M; Fabbro, M; Roche, H; Delozier, T; Labat, JP; Linassier, C; Audhuy, B; Feuilhade, F; Costa, B; Delva, R; Cure, H; Rousseau, F; Guillot, A; Mousseau, M; Ferrero, JM; Bardou, VJ; Jacquemier, J; Pouillart, P
      First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)

      BRITISH JOURNAL OF CANCER
    17. Penault-Llorca, F; Dauplat, J; Levrel, O; Pomel, C; Kwiatkowski, F; Clemenson, A; Fouilhoux, G; De Latour, M; Cure, H; Fonck, Y
      Evaluation of different grading systems for ovarian epithelial carcinoma in a series of 100 patients with uniform treatment and follow-up

      7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY
    18. HIZEL C; FERRARA M; CURE H; PEZET D; DECHELOTTE P; CHIPPONI J; RIO P; BIGNON YJ; BERNARDGALLON D
      EVALUATION OF THE 5'-SPLICED FORM OF HUMAN CATHEPSIN-B MESSENGER-RNA IN COLORECTAL MUCOSA AND TUMORS

      Oncology Reports
    19. CURE H; KRAKOWSKI I; ADENIS A; TUBIANA N; KERBRAT P; ROCHE H; CHEVALLIER B; LENTZ MA; FUMOLEAU P; CHOLLET P
      RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/

      European journal of cancer
    20. GACHON F; CHARRIER S; KWIATKOWSKI F; BESSE G; CURE H; CHASSAGNE J; FERRIERE JP; PENAULTLLORCA F; DAUPLAT J; CHOLLET P
      EXPRESSION OF CYTOSOLIC THYMIDINE KINASE IN THE PROLIFERATIVE BREAST-CARCINOMA AFTER PRIMARY CHEMOTHERAPY - THERAPEUTIC INDICATION

      European journal of cancer
    21. GUASTALLA JP; PUJADELAURAINE E; WEBER B; CURE H; ORFEUVRE H; MOUSSEAU M; VINCENT P; DIERAS V; TUBIANAMATHIEU N; JACQUIN JP; MIGNOT L; LEDUC B; VIENS P; PARISO D
      EFFICACY AND SAFETY OF THE PACLITAXEL AND CARBOPLATIN COMBINATION IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER GINECO ATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS) PHASE-II STUDY

      Annals of oncology
    22. CURE H; VANPRAAGH I; CHARRIER S; KWIATKOWSKI F; FERRIERE JP; CHOLLET P
      PHASE-I OF DOXORUBICIN AND IFOSFAMIDE ASSOCIATION FOR FIRST LINE ADVANCED BREAST-CANCER (ABC)

      Annals of oncology
    23. VINCENT P; GUASTALLA JP; PIEDBOIS P; WEBER B; GANEM G; CURE H; TRILLETLENOIR V; GOUPIL A; MIGNOT L; PUJADELAURAINE E
      TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA)

      Annals of oncology
    24. BIRON P; FUHRMANN C; CURE H; VIENS P; LEFEBVRE D; THYSS A; VIOT M; SOLERMICHEL P; ROLLIN C; GRES JJ
      CEFEPIME VERSUS IMIPENEM-CILASTATIN AS EMPIRICAL MONOTHERAPY IN 400 FEBRILE PATIENTS WITH SHORT-DURATION NEUTROPENIA

      Journal of antimicrobial chemotherapy
    25. FERRIERE JP; ASSIER I; CURE H; CHARRIER S; KWIATKOWSKI F; ACHARD JL; DAUPLAT J; CHOLLET P
      PRIMARY CHEMOTHERAPY IN BREAST-CANCER - CORRELATION BETWEEN TUMOR RESPONSE AND PATIENT OUTCOME

      American journal of clinical oncology
    26. CHARRIER S; CHASSAGNE J; CURE H; BAY JO; COMMUNAL Y; PORTEFAIX G; FERRIERE JP; BETAIL G; PLAGNE R; CHOLLET P
      MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER INDUCTION CHEMOTHERAPY RUBICIN-VINORELBINE-CYCLOPHOSPHAMIDE-FLUOROURACIL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN BREAST-CANCER

      Bone marrow transplantation
    27. BAY JO; FOUASSIER M; BEAL D; ALCARAZ L; CURE H; CHOLLET P; PLAGNE R; TRAVADE P
      AUTOIMMUNE THROMBOCYTOPENIA AFTER 6 CYCLES OF FLUDARABINE PHOSPHATE IN A PATIENT WITH CHRONIC LYMPHOTIC LEUKEMIA

      HEMATOLOGY AND CELL THERAPY
    28. CHAZAL M; CHERADAME S; FORMENTO JL; FRANCOUAL M; FORMENTO P; ETIENNE MC; FRANCOIS E; RICHELME H; MOUSSEAU M; LETOUBLON C; PEZET D; CURE H; SEITZ JF; MILANO G
      DECREASED FOLYLPOLYGLUTAMATE SYNTHETASE-ACTIVITY IN TUMORS RESISTANT TO FLUOROURACIL FOLINIC ACID TREATMENT - CLINICAL-DATA

      Clinical cancer research
    29. CHOLLET P; CHARRIER S; BRAIN E; CURE H; VANPRAAGH I; FEILLEL V; DELATOUR M; DAUPLAT J; MISSET JL; FERRIERE JP
      CLINICAL AND PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER

      European journal of cancer
    30. CHARRIER S; FERRIERE JP; KWIATKOWSKI F; CURE H; VANPRAAGH I; FEILLEL V; ASSIER I; BAY JO; DAUPLAT J; CHOLLET P
      OPTIMAL DURATION OF NEOADJUVANT CHEMOTHERAPY - 3 OR 4 VERSUS 6 CYCLESIN 3 SCHEMES FOR OPERABLE BREAST-CANCER

      European journal of cancer
    31. LEGROS M; DAUPLAT J; FLEURY J; CURE H; SUZANNE F; CHASSAGNE J; BAY JO; SOL C; CANIS M; CONDAT P; CHOUFI B; TAVERNIER F; GLENAT C; CHOLLET P; PLAGNE R
      HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE IN PATIENTS WITH STAGE-III TO STAGE-IV OVARIAN-CANCER - LONG-TERM RESULTS

      Journal of clinical oncology
    32. FERRIERE JP; CHARRIER S; CURE H; KWIATKOWSKI F; COURTADON M; BELEMBAOGO E; DELATOUR M; ACHARD JL; DAUPLAT J; CHOLLET P
      ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN-CONTAINING REGIMEN FOR 326 STAGE-II BREAST CANCERS - 15-YEAR RESULTS

      American journal of clinical oncology
    33. PUJADELAURAINE E; GUASTALLA JP; WEBER B; CURE H; ORFEUVRE H; MOUSSEAU M; VINCENT P; DIERAS V; TUBIANAMATHIEU N; JACQUIN JP; MIGNOT L; LEDUC B; PARAISO D; VIENS P
      EFFICACY AND SAFETY OF THE COMBINATION PACLITAXEL CARBOPLATIN IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED OVARIAN-CARCINOMA - A MULTICENTER FRENCH GATEURS-NATIONAUX-POUR-LETUDE-DES-CANCERS-OVARIENS PHASE-II STUDY/

      Seminars in oncology
    34. SATGE D; SASCO AJ; CURE H; LEDUC B; SOMMELET D; VEKEMANS MJ
      AN EXCESS OF TESTICULAR GERM-CELL TUMORS IN DOWNS-SYNDROME - 3 CASE-REPORTS AND A REVIEW OF THE LITERATURE

      Cancer
    35. CURE H; CHARRIER S; FERRIERE JP; VANPRAAGH I; ASSIER I; FEILLEL V; DELATOUR M; BAY JO; ACHARD JL; DAUPLAT J; CHOLLET P
      RESULTS OF 3 NEOADJUVANT CHEMOTHERAPY REG IMEN FOR OPERABLE BREAST-CANCER

      Bulletin du cancer
    36. FLEURY J; LEGROS M; COLOMBAT P; CURE H; TRAVADE P; TORTOCHAUX J; DIONET C; CHOLLET P; LINASSIER C; LAMAGNERE JP; BLAISE D; VIENS P; MARANINCHI D; PLAGNE R
      HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRSTCOMPLETE OR PARTIAL REMISSION FOR POOR-PROGNOSIS HODGKINS-DISEASE

      Leukemia & lymphoma
    37. DUFOUR P; HUSSEINI F; DREYFUS B; CURE H; MARTIN C; PREVOST G; OLIVIER JP; DUMAS F; DUCLOS B; OLIVARES R; LESZLER A; BERGERAT JP; AUDHUY B; THILL L; OBERLING F
      5-FLUOROURACIL VERSUS 5-FLUOROURACIL PLUS ALPHA-INTERFERON AS TREATMENT OF METASTATIC COLORECTAL-CARCINOMA - A RANDOMIZED STUDY

      Annals of oncology
    38. CHOLLET P; BENSMAINE MA; BRIENZA S; DELOCHE C; CURE H; CAILLET H; CVITKOVIC E
      SINGLE-AGENT ACTIVITY OF OXALIPLATIN IN HEAVILY PRETREATED ADVANCED EPITHELIAL OVARIAN-CANCER

      Annals of oncology
    39. BACIN F; UROSEVIC V; CURE H; MADELMONT JC; VEYRE A; CHOLLET P
      CHEMOTHERAPY OF METASTATIC UVEAL MELANOMA USING CYSTEMUSTINE

      Vision research
    40. PORTEFAIX G; COMMUNAL Y; FLEURY J; CURE H; CHOUFI B; FOUASSIER M; BONS JM; GLENAT C; CHOLLET P; CHASSAGNE J; PLAGNE R; LEGROS M
      INTEREST OF HIGH FLUORESCENCE RETICULOCYTES (HFR)EVALUATION IN OPTIMAL TIME DETERMINATION OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HAVESTING

      Blood
    41. BERNARDGALLON D; GOSSE S; ESSIOUX L; LAURENTPUIG P; RALLIERE C; CURE H; BAY JO; SCHRAUB S; BONAITIPELLIE C; SOBOL H; BIGNON YJ
      ANALYSES OF LINKAGE TO 17Q11-Q23 IN 3 FRENCH HEREDITARY NONPOLYPOSIS COLON-CANCER FAMILIES

      International journal of oncology
    42. BERNARDGALLON D; RALLIERE C; ESSIOUX L; GOSSE S; CURE H; BAY JO; SCHRAUB S; BONAITIPELLIE C; SOBOL H; BIGNON YJ
      LINKAGE ANALYSES OF 3 FRENCH FAMILIES TO LOCI ON CHROMOSOME-2P AND CHROMOSOME-3P PREDISPOSING TO HEREDITARY NONPOLYPOSIS COLON-CANCER

      International journal of oncology
    43. VANPRAGGH I; FERRIERE JP; CURE H; FEILLEL V; LEBOUEDEC G; DELATOUR M; ROLHION C; CHARRIER S; ASSIER I; MISSET JL; DAUPLAT J; CHOLLET P
      COMPARISON OF 3 NEOADJUVANT CHEMOTHERAPY REGIMENS FOR OPERABLE BREAST-CANCER

      European journal of cancer
    44. CURE H; RICHARD JF; ASSIER I; SLIM K; CLARK L; PEZET D; CHIPPONI J
      THP ADRIAMYCIN (THP) - A PALLIATIVE TREATMENT OF LOCAL ADVANCED NON OPERABLE HEPATOCELLULAR-CARCINOMA (HCC)

      European journal of cancer
    45. LEGROS M; FLEURY J; CURE H; CONDAT P; LENAT A; SUBTIL E; SANDERSON D; COMMUNAL Y; BASILE M; TAVERNIER F; CHOUFFI B; CHOLLET P; PLAGNE R; CHASSAGNE J
      NEW METHOD FAIR STEM-CELL QUANTIFICATION - APPLICATIONS TO THE MANAGEMENT OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    46. FLEURY J; LEGROS M; CURE H; TORTOCHAUX J; CONDAT P; DIONET C; TRAVADE P; BELEMBAOGO E; TAVERNIER F; KWIATKOWSKI F; CHOLLET P; PLAGNE R
      THE HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN HODGKINS-DISEASE - QUESTIONS AND CONTROVERSIES

      Leukemia & lymphoma
    47. SLIM K; PEZET D; BERARD JP; PIECH JJ; CURE H; CHIPPONI J
      CANCER OF THE ESOPHAGUS - NEOADJUVANT CHE MOTHERAPY AND POSTOPERATIVEMORBIDITY

      La Presse medicale
    48. CURE H
      IATROGENIC ACCIDENTS OF GERMINAL TUMORS C HEMOTHERAPY

      Pathologie et biologie
    49. LEGERENREILLE A; CURE H; PEZET D; BARGNOUX PJ
      PHARMACOKINETIC STUDY IN CARBOPLATIN, CISPLATIN AND 5-FLUOROURACIL REGIMEN FOR ADVANCED ESOPHAGEAL CANCER

      Anticancer research
    50. BEAL D; FLEURY J; CURE H; SUREAU I; LEBOUEDEC G; DELATOUR M; PLAGNE R
      ASSOCIATION OF BREAST-CANCER AND KLINEFEL TERS-SYNDROME

      La Semaine des hopitaux de Paris
    51. JANNY P; CURE H; MOHR M; HELDT N; KWIATKOWSKI F; LEMAIRE JJ; PLAGNE R; ROZAN R
      LOW-GRADE SUPRATENTORIAL ASTROCYTOMAS - MANAGEMENT AND PROGNOSTIC FACTORS

      Cancer
    52. FLEURY J; TORTOCHAUX J; LEGROS M; CURE H; KWIATKOWSKI F; FERRIERE JP; TRAVADE P; DIONET C; GAILLARD G; CHASSAGNE J; BIGNON YJ; VANPRAAGH I; BELEMBAOGO E; CHOLLET P; PLAGNE R
      PRONOSTIC VALUE OF BETA-2-MICROGLOBULIN I N YOUNG-ADULTS WITH HODGKINS-DISEASE

      Bulletin du cancer
    53. CURE H
      ASCO MEETING - CANCERS OF THE URINARY-TRA CT AND PROSTATE-CANCER - ORLANDO (FL), MAY, 16-22, 1993

      Bulletin du cancer
    54. LEGROS M; FLEURY J; CURE H; BASILE M; CHOUFI B; COMMUNAL Y; CHOLLET P; TRAVADE P; CONDAT P; PLAGNE R; CHASSAGNE J
      R-HU GM-CSF AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE - AN UNICENTER RANDOMIZED STUDY OF 50 PATIENTS

      Blood
    55. ATTIASOBOL J; FERRIERE JP; CURE H; KWIATKOWSKI F; ACHARD JL; VERRELLE P; FEILLEL V; DELATOUR M; LAFAYE C; DELOCHE C; DAUPLAT J; DOLY A; ROZAN R; CHOLLET P
      TREATMENT RESULTS, SURVIVAL AND PROGNOSTIC FACTORS IN 109 INFLAMMATORY BREAST CANCERS - UNIVARIATE AND MULTIVARIATE-ANALYSIS

      European journal of cancer
    56. CURE H; PEZET D; FLEURY J; SLIM K; CHOLLET P; PLAGNE R; CHIPPONI J
      IS ESOPHAGEAL CANCER CHEMOSENSITIVE - SIG NIFICANCE OF A COMBINATION OF 2 PLATINUM SALTS (CARBOPLATIN AND CISPLATIN) AND FLUOROURACIL

      La Revue de medecine interne
    57. LEBOUEDEC G; KAUFFMANN P; CURE H; FEILLEL V; DAUPLAT J
      TAMOXIFEN AND THE ENDOMETRIUM - REVIEW OF 50 CASES OF ABNORMAL UTERINE BLEEDING

      La Revue de medecine interne
    58. BERNARD D; BIGNON YJ; LAVENUE F; PAUCHARD J; DEMEOCQ F; TRAVADE P; PHILIPPE P; LEGROS M; CURE H; CHASSAGNE J; CHOLLET P; PLAGNE R
      LINEAGE PROMISCUITY IN LEUKEMIA STUDIES OF T-CELL RECEPTOR AND IMMUNOGLOBULIN GENES

      Leukemia research
    59. LALLE P; STOPPALYONNET D; MAZOYER S; RIO P; GIRODET C; HARDOUIN A; NAROD SA; SOBOL H; BIGNON YJ; LARRA F; LORTHOLARY A; PIET L; LAITHIER V; VUILLIER J; DILHUYDY MH; LONGY M; TOULOUSE C; COUETTE JE; HARDOUIN A; SWITSUS O; CHAMOUTON C; BIGNON YJ; PLAGNE R; PETIT MF; CURE H; CUISENIER J; LIZARD S; NIVELON; TEYSSIER JY; MOUSSEAU; LEROUX D; VROUSOS; SCHAERER; VENNIN P; DEMAILLE MC; DECIGNY N; GRANIER AM; DEYRAT JP; SOBOL H; DESSEIGNE F; FRAPPAZ D; FERVERS B; EISINGER F; FABBRO; LUPORSI E; LEHEUP B; SOMMELET D; MAUGAUDLOUBOUTIN C; FRENAY M; GESTA P; THOMAS G; OLSCHWANG S; DELETTRE O; AURIAS A; ZUMMER; HAGUENAUER O; GRANDJOUAN S; DEMANGE L; DANELMOORE L; LEVEQUE J; NOGUES C; PETIT JC; FRICKER JP; LIMACHER JM; ROUMAGNAC M; LAPEYRE M; DREYFUS HR; GRANDJOUAN S; SCHLUMBERGER M; BRUGIERES L; JANIN N; AVRIL MF
      GENETIC PREDISPOSITION TO BREAST-CANCER A ND OVARIAN-CANCER

      Bulletin du cancer
    60. LEGROS M; FLEURY J; CURE H; BASILE M; SOL C; CONDAT P; KWIATKOWSKI F; PLAGNE R; CHASSAGNE J
      A NEW METHOD OF STEM-CELL QUANTIFICATION - PRACTICAL APPLICATIONS IN THE MANAGEMENT OF PBPC TRANSPLANTATION

      Blood
    61. LEGROS M; FLEURY J; BASILE M; CURE H; TAVERNIER F; CONDAT P; CHOLLET P; PLAGNE R; CHASSAGNE J
      PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION AFTER HIGH-DOSE OF CYCLOPHOSPHAMIDE (CTX) PLUS ETOPOSIDE (VP16) AND RHU-GM-CSF (MOLGRAMOSTIM)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 02:21:02